By Samantha Reynolds Globus Medical (NASDAQ: GMED) recently received a number of ratings updates from brokerages and research firms: 5/7/2015 – Globus Medical was upgraded by analysts at Zacks from a “hold” rating to a “buy” rating. They now have a $28.00 price